Phase II study of antineoplastons A10 and AS2-1 in patients with primary central nervous system lymphoma
Latest Information Update: 08 Jul 2013
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 12 Dec 2006 Status change
- 25 Aug 2005 New trial record.